Rare diseases
Investigational molecules
Locations
Recruiting trials first
3 clinical trials in this condition
A study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
GermanyStudy on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
FranceStudy on the Effectiveness and Safety of Barzolvolimab for Patients with Chronic Inducible Urticaria
BulgariaIn short
Cold urticaria is a rare condition where the body reacts to cold temperatures by developing itchy red welts or hives, sometimes within minutes of exposure. While many people may feel uncomfortable in cold weather, those with this condition experience an allergic-type response that can range from mild skin reactions to serious complications affecting the entire body.
If you notice red, itchy welts appearing on your skin shortly after being exposed to cold temperatures, it's important to see a healthcare professional. This might happen after swimming in cold water, walking outside in cold weather, eating or drinking something cold, or even just holding a cold object. While these symptoms might seem minor at first, proper diagnosis is essential because some people with cold urticaria can experience severe reactions.
You should seek medical attention even if your reactions seem mild. Your healthcare provider will want to rule out other conditions that might be causing similar symptoms. Early diagnosis helps you understand your triggers and learn how to protect yourself from potentially dangerous situations. Since cold urticaria can sometimes be associated with underlying health conditions such as blood disorders, viral infections, or other diseases, getting a proper evaluation is an important step in managing your overall health.
Young adults between the ages of 18 and 30 are most commonly affected by cold urticaria, though it can appear at any age, from early childhood to later in life. The condition affects women slightly more often than men. If you have a family member with cold urticaria, you might be at higher risk of developing it yourself, though most people who get this condition have no family history of it.
Diagnosing cold urticaria typically starts with your doctor taking a detailed medical history. They will ask you specific questions about when you first noticed symptoms, what seems to trigger your reactions, and whether anyone in your family has similar problems. Your doctor may also inquire about recent illnesses, new medications you've started, whether you've traveled to new places, or if you've eaten any new foods. These questions help build a picture of your condition and rule out other possible causes of your symptoms.
The primary test used to diagnose cold urticaria is called the cold stimulation test, also known as the ice cube test. This is a simple, quick procedure that can usually be performed right in your doctor's office. During this test, your healthcare provider places an ice cube on your skin, typically on your forearm, for a few minutes. The ice cube is usually placed in a plastic bag to prevent water from affecting the results. After about five minutes, the ice cube is removed, and your doctor waits to see what happens as your skin warms up.
If you have cold urticaria, a distinct red, swollen bump or hive will develop in the area where the ice cube was placed. This reaction typically appears within several minutes after the ice is removed and your skin begins to rewarm. The development of this hive is considered a positive test result. In some cases, the test may be repeated at shorter time intervals to determine the minimum amount of time needed for cold exposure to trigger a reaction. This information can help your doctor understand the severity of your condition.
However, it's important to know that not everyone with cold urticaria will have a positive ice cube test. Some people have what doctors call atypical forms of the condition, where the test might not show a reaction even though they clearly have symptoms when exposed to cold in everyday life. In these cases, your doctor will rely more heavily on your medical history and description of symptoms to make the diagnosis.
The familial or hereditary type of cold urticaria may require different testing. Instead of just placing an ice cube on the skin, diagnosing this type might involve exposing a person to cold air for a longer period of time. This is because familial cold urticaria symptoms can take much longer to appear, sometimes showing up anywhere from 30 minutes to 48 hours after cold exposure, rather than just a few minutes.
Once cold urticaria is suspected or confirmed, your healthcare provider might recommend additional blood tests. These tests serve an important purpose: they help identify any underlying diseases or infections that might be associated with your cold urticaria. Some conditions that have been linked to cold urticaria include certain blood cancers like chronic lymphocytic leukemia, blood disorders such as cryoglobulinemia (a condition where proteins in the blood gel together in response to cold), and various infections including mononucleosis, chickenpox, hepatitis, and syphilis.
Complete blood counts and metabolic tests may be performed to check for these associated conditions. These tests examine your blood cells and look for abnormalities in blood chemistry that might point to an underlying problem. Finding and treating any underlying condition is an important part of managing cold urticaria, since in some cases, treating the underlying problem can help improve the cold urticaria symptoms.
Your doctor will also want to distinguish cold urticaria from other types of urticaria or hives. Some people have multiple types of urticaria at the same time. For example, cold urticaria commonly occurs alongside other physical urticarias such as dermographism (hives that appear when the skin is scratched or rubbed) and cholinergic urticaria (hives triggered by heat, exercise, or stress). Understanding all the triggers for your hives helps your doctor create the most effective treatment plan.
When patients with cold urticaria are being considered for enrollment in clinical trials, more detailed and standardized diagnostic procedures may be used. Clinical trials often require precise documentation of the condition to ensure that all participants truly have cold urticaria and to measure how well new treatments work.
In the research setting, the cold stimulation test is performed with very specific parameters. The test stimulus is typically set at a temperature between 0 and 4 degrees Celsius. The cold object, often an ice cube in a plastic bag, is placed on the inner surface of the forearm for exactly five minutes. After removal, researchers observe the skin for five to ten minutes while it rewarms. A positive test is defined as the development of a visible weal (raised bump) in the area that was exposed to cold.
Some clinical trials may use a modified version called the cold stimulation time test. In this variation, the ice cube test is repeated multiple times using shorter exposure periods. This helps researchers determine the minimum amount of time that cold exposure must last before it triggers a reaction in that particular patient. This threshold can vary greatly from person to person. Some individuals react after just one or two minutes of cold exposure, while others need longer contact with cold before symptoms appear. Knowing this threshold helps researchers understand the severity of the condition and track whether treatments are making the reactions less sensitive over time.
Clinical trials may also track additional information about your reactions. Researchers might document the size of the hives that develop, how long they last, and whether they're accompanied by other symptoms like itching, burning, swelling, or more widespread reactions. They may take photographs of the skin reactions to create a visual record of changes over time.
Blood tests in the clinical trial setting often go beyond basic screening. Researchers may measure specific markers in your blood related to the allergic response. For example, they might check levels of histamines (chemicals released by your immune system that cause allergy symptoms) or other inflammatory markers. These measurements help researchers understand the biological mechanisms behind cold urticaria and evaluate whether experimental treatments are working at a cellular level.
Some studies might also perform tests to rule out a related but different condition called familial cold autoinflammatory syndrome (FCAS), which was previously known as familial cold urticaria. FCAS is a genetic condition that has some similar symptoms but is actually quite different from acquired cold urticaria. Genetic testing may be done to identify mutations in specific genes, particularly the CIAS1 gene, which is associated with FCAS. This distinction is important because the treatment and prognosis for FCAS differ from those for typical cold urticaria.
Quality of life assessments are another important component of clinical trial diagnostics. Researchers use standardized questionnaires to understand how much cold urticaria affects your daily activities, work, school, family life, and social interactions. These assessments help measure the overall impact of the condition beyond just the physical symptoms. They also help researchers determine whether new treatments improve patients' lives in meaningful ways, not just whether they reduce the number or size of hives.
Clinical trials may also require documentation of any history of severe reactions or anaphylaxis. This information is crucial for safety monitoring during the study and helps researchers identify which patients might be at higher risk for complications. If you've ever experienced a severe reaction to cold, especially during activities like swimming, this would be carefully documented and considered when determining if a particular clinical trial is safe for you to participate in.
The outlook for people with cold urticaria varies considerably from person to person. The condition can be unpredictable in how long it lasts and how severe the symptoms become. For many people, cold urticaria is a chronic condition that persists for several years, though the intensity of symptoms may fluctuate over time.
Research shows that the average duration of cold urticaria ranges from about 4.8 to 9.3 years. This means that most people who develop this condition will live with it for multiple years before it resolves. However, there is good news: in many cases, cold urticaria does eventually go away on its own. Studies indicate that approximately 50% of people with cold urticaria experience improvement within about five years of when their symptoms first appeared.
For some individuals, the condition may resolve much sooner. Some people find that their symptoms disappear after just a few weeks or months. In others, particularly those with the acquired form, symptoms may persist longer. The familial or hereditary type of cold urticaria tends to be lifelong, since it is passed down through families and is related to genetic factors.
Several factors can influence the prognosis. The presence of an underlying condition such as a viral infection or blood disorder can affect how long cold urticaria lasts and how well it responds to treatment. In cases where cold urticaria is secondary to another health problem, treating that underlying condition may lead to improvement or resolution of the cold urticaria symptoms.
The impact on quality of life can be significant. Many people with cold urticaria find themselves limiting their activities to avoid triggering symptoms. They may avoid swimming, outdoor winter activities, or even simple tasks like reaching into a freezer or drinking cold beverages. This constant vigilance and activity restriction can affect work, school, family life, and social relationships. Studies have found that a large percentage of people with cold urticaria report that the condition impacts their job performance, leading to missed work days and sometimes even job changes.
With proper management, including avoiding triggers and taking medications as prescribed, most people with cold urticaria can control their symptoms and maintain a good quality of life. The risk of severe reactions can be minimized by taking precautions, carrying emergency medication when prescribed, and educating family members and friends about the condition.
Cold urticaria itself is not typically a life-threatening condition, and the vast majority of people with this disorder have a normal life expectancy. The condition does not directly cause death or significantly shorten lifespan. In research studies involving thousands of patients with cold urticaria, there have been no reported fatalities directly attributed to cold-induced symptoms.
However, it's important to understand that while cold urticaria itself doesn't affect survival, severe reactions can be dangerous in certain situations. The most serious risk comes from experiencing anaphylaxis, a severe allergic reaction that affects the whole body. Research shows that the percentage of patients who experience anaphylaxis from cold urticaria ranges widely, from 0% to 34% depending on the study. Though this sounds concerning, it's important to note that anaphylaxis is treatable with emergency medication, particularly epinephrine injections, and deaths from cold urticaria are extremely rare.
The situations that pose the highest risk are those where large areas of the body are suddenly exposed to cold, particularly during activities like swimming or jumping into cold water. If a person with cold urticaria experiences a severe reaction while in water, they could potentially faint, which could lead to drowning. This is why healthcare providers strongly advise people with cold urticaria to be extremely cautious around cold water and to avoid swimming alone.
Long-term outcomes are generally favorable. Studies tracking patients over time have found that about 14% of adults with cold urticaria see their condition completely resolve within five years, and about 43% experience complete resolution within ten years. This means that while cold urticaria may be a chronic condition for several years, there is a good chance it will eventually go away on its own.
For people who have cold urticaria as a symptom of an underlying serious condition, such as certain blood cancers, the overall prognosis depends more on that underlying condition than on the cold urticaria itself. In these cases, treating the underlying disease becomes the priority, and improvement in cold urticaria symptoms may follow.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
